Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Renalase ELISA Kit (AC3373)
Cat.#: ASET-1962
Specifications
Description Mouse Renalase ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Renalase concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.249 U/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 4-64 U/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2419 Horse BDNF ELISA Kit (AC3830) Quantitative inquiry ASET-1258 Human PCDH1 ELISA Kit (AC2669) Quantitative inquiry ASET-1809 Human Ephrin B2 ELISA Kit (AC3220) Quantitative inquiry ASET-2393 Mouse Wnt5a ELISA Kit (AC3804) Quantitative inquiry ASET-1678 Mouse Twist ELISA Kit (AC3089) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-2367 Rat GLP1 ELISA Kit (AC3778) Quantitative inquiry ASET-1825 Mouse NRG4 ELISA Kit (AC3236) Quantitative inquiry ASET-2153 Mouse GDF7 ELISA Kit (AC3564) Quantitative inquiry ASET-1533 Human Ephrin A1 ELISA Kit (AC2944) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket